Klingman & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Klingman & Associates's AMGN Position: Q1 2026 in Review
Klingman & Associates increased its Amgen (AMGN) stake by 3.5% in Q1 2026, buying an estimated $25.3K and bringing the position to 2,097 shares worth $738K. The position accounts for 0.04% of the portfolio, ranked #162.
Klingman & Associates first reported a position in AMGN in Q4 2015 and has held it in 24 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Klingman & Associates held 2,097 shares of Amgen worth $738K as of Q1 2026.
- Klingman & Associates bought 71 Amgen shares in Q1 2026, an estimated $25.3K.
- Amgen made up 0.04% of Klingman & Associates's portfolio in Q1 2026, its #162 holding.
- Klingman & Associates first reported a position in Amgen in Q4 2015 and has held it in 24 quarters since.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.